Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL paediatric influenza vaccine safety and immunogenicity study
2015-004820-69Phase 3
- Sponsor
- CSL Limited
- Start
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Afluria in influenza, sponsored by CSL Limited. Primary endpoint: Safety of CSL Influenza Virus Vaccine in a paediatric population.
02
Drugs
Afluria
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-004820-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004820-69.